Severe facial lipoatrophy Program in Pharmaceutical Benefits Scheme (PBS) 012-18051129
This document outlines details of the PBS subsidised polylactic acid (PLA) for patients with HIV associated severe facial lipoatrophy.
Note: For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.